Action Potential Venture Capital

0 followers


Action Potential Venture Capital (APVC) is GSK's bioelectronic medicines venture fund. APVC is focused on the next generation of peripheral neuromodulation medical devices and invests in companies and technologies that enable the future of targeted and adaptive bioelectronics.

Industries

Employees

Links

Org chart

Partners

Collapse
Rami Elghandour
Executive in Residence
Suraj Mudichintala
Senior Associate